US · Healthcare

Lisata Therapeutics Inc. (LSTA)

Biotechnology

Lisata Therapeutics Inc. (LSTA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for LSTA

P/E ratio

25.00

Lisata Therapeutics Inc. (LSTA) — FAQ

What is LSTA's P/E ratio?

The price-to-earnings (P/E) ratio for Lisata Therapeutics Inc. (LSTA) is 25.00 (data as of 2026-05-23).

Does Lisata Therapeutics Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Lisata Therapeutics Inc. (LSTA). Check the MyAverix Finance app for the latest dividend data.

What sector is Lisata Therapeutics Inc. in?

Lisata Therapeutics Inc. (LSTA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is LSTA listed on?

LSTA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)